| Protein Variants | Comment | Organism |
|---|---|---|
| F55G | site-directed mutagenesis, the nonconservative mutant is predicted to be inactive by molecular modeling analyses | Homo sapiens |
| F55Y | site-directed mutagenesis, the conservative mutant is expected to be active by molecular modeling analyses, molecular docking of vitK1E to the F55G mutant | Homo sapiens |
| F83G | site-directed mutagenesis, the nonconservative mutant is predicted to be inactive by molecular modeling analyses, a loss of hydrogen bonds to S52 and S81 induced by the F83G mutation leads to a rotation of vitK1E away from the active site, also facing TM2 | Homo sapiens |
| N80G | site-directed mutagenesis, the nonconservative mutant is predicted to be inactive by molecular modeling analyses, molecular docking of vitK1E to the N80G mutant. The N80G mutation induces a loss of hydrogen bonds to S52 and S81, leading vitK1E to rotate away from C135 | Homo sapiens |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| warfarin | molecular docking and dynamics of VKORC1-vitamin epoxide K and VKORC1-warfarin complexes, overview. Activity assay data are fitted by nonlinear regression to the noncompetitive inhibition model | Homo sapiens |
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| microsome | - |
Homo sapiens | - |
- |
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 2,3-epoxyphylloquinone + a protein with reduced L-cysteine residues | Homo sapiens | - |
phylloquinone + a protein with a disulfide bond + H2O | - |
? | |
| phylloquinone + a protein with reduced L-cysteine residues | Homo sapiens | - |
phylloquinol + a protein with a disulfide bond | - |
? |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | Q9BQB6 | - |
- |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 2,3-epoxyphylloquinone + a protein with reduced L-cysteine residues | - |
Homo sapiens | phylloquinone + a protein with a disulfide bond + H2O | - |
? | |
| phylloquinone + a protein with reduced L-cysteine residues | - |
Homo sapiens | phylloquinol + a protein with a disulfide bond | - |
? | |
| vitamin K1 + MK4 epoxide + DTT | - |
Homo sapiens | ? | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| vitamin K epoxide reductase | - |
Homo sapiens |
| VKORC1 | - |
Homo sapiens |
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 37 | - |
assay at | Homo sapiens |
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| 7.4 | - |
assay at | Homo sapiens |
| General Information | Comment | Organism |
|---|---|---|
| additional information | VKORC1 enzymatic site structure and function analysis, molecular modeling. Residues F55, N80, and F83 are crucial for vitamin K epoxide binding. Residues F55, N80, and F83 appear to act in a concerted manner to keep vitamin K epoxide close to the C135 catalytic residue. Residues F55 and N80 prevent naphthoquinone head rotation away from the active site, assisted by residue F83 that prevents vitamin K from sliding outside the enzymatic pocket, through hydrophobic tail stabilization. Molecular docking and dynamics of VKORC1-vitamin epoxide K and VKORC1-warfarin complexes, molecular simulations, overview. Substrate binding structure analysis | Homo sapiens |
| physiological function | the vitamin K epoxide reductase (VKORC1) enzyme is of primary importance in many physiological processes, i.e. blood coagulation, energy metabolism, and arterial calcification prevention, due to its role in the vitamin K cycle. VKORC1 catalyzes reduction of vitamin K epoxide to quinone and then to hydroquinone | Homo sapiens |